Sana Biotechnology (SANA) is the lead sponsor of 3 active clinical trials listed on ClinicalTrials.gov[2], including 3 Phase 1[1].
SANA has 1 Form 4 insider filing recorded at the SEC in the past 30 days[3].
SANA is tracked by BiotechSigns with a current catalyst score of 41/100 and grade D. The page summarizes 0 active signals, including 0 PDUFA, 0 insider buying, and 0 clinical trial signals, with data refreshed on 2026-06-03.
Sana Biotechnology (SANA) is the lead sponsor of 3 active clinical trials listed on ClinicalTrials.gov[2], including 3 Phase 1[1].
SANA has 1 Form 4 insider filing recorded at the SEC in the past 30 days[3].